{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06270719",
            "orgStudyIdInfo": {
                "id": "SRP-9001-401"
            },
            "organization": {
                "fullName": "Sarepta Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy",
            "officialTitle": "A Long-term Multicenter Prospective Observational Study Evaluating the Comparative Effectiveness and Safety of Sarepta Gene Transfer Therapy vs. Standard of Care in Participants With Duchenne Muscular Dystrophy Under Conditions of Routine Clinical Practice",
            "acronym": "ENDURE",
            "therapeuticArea": [
                "Other"
            ],
            "study": "an-observational-study-comparing-delandistrogene-moxeparvovec-with-standard-of-care-in-participants-with-duchenne-muscular-dystrophy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2038-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-24",
            "studyFirstSubmitQcDate": "2024-02-13",
            "studyFirstPostDateStruct": {
                "date": "2024-02-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-12",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sarepta Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multicenter, prospective, observational Phase 4 study in the United States. The study is designed to collect both medical history and prospective data on Duchenne muscular dystrophy (DMD) treatment outcomes in participants receiving delandistrogene moxeparvovec as part of clinical care, compared to participants with DMD receiving or prescribed to start chronic glucocorticoid treatment at baseline in routine clinical practice. In addition, treatment outcomes will be collected prospectively from post-trial participants who have received delandistrogene moxeparvovec through participation in select SRP-9001 studies."
        },
        "conditionsModule": {
            "conditions": [
                "Duchenne Muscular Dystrophy"
            ],
            "keywords": [
                "Duchenne Muscular Dystrophy",
                "DMD",
                "Observational",
                "Standard of Care",
                "Phase 4"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 500,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Delandistrogene Moxeparvovec",
                    "description": "Participants were either (1) prescribed delandistrogene moxeparvovec commercially as part of clinical care prior to entry into this trial or (2) previously received delandistrogene moxeparvovec through participation in select SRP-9001 studies.",
                    "interventionNames": [
                        "Genetic: delandistrogene moxeparvovec"
                    ]
                },
                {
                    "label": "Standard of Care",
                    "description": "Participants unexposed to DMD gene therapy receiving standard of care therapy (chronic glucocorticoid treatment) that does not include delandistrogene moxeparvovec or other DMD gene therapies.",
                    "interventionNames": [
                        "Drug: Standard of Care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "delandistrogene moxeparvovec",
                    "description": "No study medication will be provided by the sponsor during this trial.",
                    "armGroupLabels": [
                        "Delandistrogene Moxeparvovec"
                    ],
                    "otherNames": [
                        "SRP-9001",
                        "delandistrogene moxeparvovec-rokl",
                        "ELEVIDYS"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Standard of Care",
                    "description": "No study medication will be provided by the sponsor during this trial.",
                    "armGroupLabels": [
                        "Standard of Care"
                    ],
                    "otherNames": [
                        "Chronic glucocorticoid treatment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "All Cohorts: Mean Change From Baseline in Time to Walk/Run 10 Meters (and Calculated Velocity) at Month 12",
                    "timeFrame": "Baseline, Month 12"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "All Cohorts: Time to Rise From Floor (Supine to Stand)",
                    "timeFrame": "Up to 10 years"
                },
                {
                    "measure": "All Cohorts: Loss of Ambulation (LOA)",
                    "timeFrame": "Up to 10 years"
                },
                {
                    "measure": "All Cohorts: Performance of Upper Limb (PUL) Version 2.0 Entry Item Score",
                    "timeFrame": "Up to 10 years"
                },
                {
                    "measure": "All Cohorts: Patient-reported Outcomes Measurement Information (PROMIS) Domain Scores of Mobility, Upper Extremity and Fatigue",
                    "timeFrame": "Up to 10 years"
                },
                {
                    "measure": "All Cohorts: Pulmonary Function, as Measured Forced Vital Capacity (FVC) (% Predicted)",
                    "timeFrame": "Up to 10 years"
                },
                {
                    "measure": "All Cohorts: Cardiac Function, Including Left Ventricular Ejection Fraction (LVEF) as Measured by Echocardiogram (ECHO)",
                    "timeFrame": "Up to 10 years"
                },
                {
                    "measure": "All Cohorts: Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)",
                    "timeFrame": "Up to 10 years"
                },
                {
                    "measure": "Delandistrogene Moxeparvovec Cohorts: Time to Walk/Run 10 Meters (Calculated Velocity)",
                    "timeFrame": "Up to 10 years"
                },
                {
                    "measure": "Delandistrogene Moxeparvovec Post-trial Cohort: North Star Ambulatory Assessment (NSAA)",
                    "timeFrame": "Up to 10 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n- Has a definitive diagnosis of DMD prior to Screening based on documentation of clinical findings and confirmatory genetic testing.\n\nAmong participants recruited from routine clinical practice:\n\n* Is aged 4 through 5 years at the time of enrollment.\n* Is ambulatory per protocol specified criteria.\n* Is currently receiving or has been prescribed to start chronic glucocorticoid therapy at the time of this observational study enrollment.\n\nFor Delandistrogene Moxeparvovec-exposed Participants:\n\n- Will be initiating usual care treatment with delandistrogene moxeparvovec at the time of study enrollment.\n\nFor Comparators:\n\n- Is unexposed to DMD gene therapy at the time of study enrollment.\n\nExclusion Criteria:\n\nAmong participants recruited from routine clinical practice:\n\n* Has any deletion of exon 8 and/or exon 9 in the DMD gene.\n* Is currently participating in any DMD interventional study at the time of this observational study enrollment.\n* Has a medical condition or confounding circumstances (for example, prior traumatic limitation for mobility or significant behavioral comorbidity) that, in the opinion of the Investigator, might compromise:\n\n  * The participant's ability to comply with the protocol-required procedures,\n  * The participant's wellbeing or safety, and/or\n  * The clinical interpretability of the data collected from the participant.\n\nOther inclusion/exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "minimumAge": "4 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "DMD participants within each prescriber's practice who either (1) have been prescribed delandistrogene moxeparvovec or (2) are receiving or have been prescribed to begin chronic glucocorticoid therapy in routine clinical practice, and who meet the study eligibility criteria, will be invited to enroll into the study and will be followed according to the protocol.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sarepta Therapeutics Inc. For Clinical Trial Information, Select Option 4",
                    "role": "CONTACT",
                    "phone": "1-888-SAREPTA (1-888-727-3782)",
                    "email": "SareptAlly@sarepta.com"
                }
            ],
            "locations": [
                {
                    "facility": "Arkansas Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Little Rock",
                    "state": "Arkansas",
                    "zip": "72202",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "SareptAlly@sarepta.com"
                        },
                        {
                            "name": "Aravindhan Veerapandiyan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.74648,
                        "lon": -92.28959
                    }
                },
                {
                    "facility": "Nicklaus Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33155",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "SareptAlly@sarepta.com"
                        },
                        {
                            "name": "Migvis Monduy, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Indiana Clinical and Translational Science Institute",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46202",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "SareptAlly@sarepta.com"
                        },
                        {
                            "name": "Marcia Felker, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Penn State Health Milton S. Hershey Medical Center",
                    "status": "RECRUITING",
                    "city": "Hershey",
                    "state": "Pennsylvania",
                    "zip": "17033",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "SareptAlly@sarepta.com"
                        },
                        {
                            "name": "Ashutosh Kumar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.28592,
                        "lon": -76.65025
                    }
                },
                {
                    "facility": "Cook Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Fort Worth",
                    "state": "Texas",
                    "zip": "76104",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "SareptAlly@sarepta.com"
                        },
                        {
                            "name": "Warren Marks, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.72541,
                        "lon": -97.32085
                    }
                },
                {
                    "facility": "Children's Hospital of the King's Daughters",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23507",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "SareptAlly@sarepta.com"
                        },
                        {
                            "name": "Crystal Proud, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009136",
                    "term": "Muscular Dystrophies"
                },
                {
                    "id": "D000020388",
                    "term": "Muscular Dystrophy, Duchenne"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020966",
                    "term": "Muscular Disorders, Atrophic"
                },
                {
                    "id": "D000009135",
                    "term": "Muscular Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12093",
                    "name": "Muscular Dystrophies",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22185",
                    "name": "Muscular Dystrophy, Duchenne",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12092",
                    "name": "Muscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4589",
                    "name": "Atrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "M22697",
                    "name": "Muscular Disorders, Atrophic",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "T3963",
                    "name": "Muscular Dystrophy",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T698",
                    "name": "Becker Muscular Dystrophy",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1945",
                    "name": "Duchenne Muscular Dystrophy",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "asFound": "Single Arm Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}